| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/26/2008 | US20080153805 Sulfonamide derivatives |
| 06/26/2008 | US20080153800 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(1-methylethyl)oxy]-N-1H-pyrazol-3-ylbenzamide; glucokinase (GLK or GK) activator; type II diabetes |
| 06/26/2008 | US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma, |
| 06/26/2008 | US20080153778 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |
| 06/26/2008 | US20080153775 Weight reduction program and method |
| 06/26/2008 | US20080153766 Non-insulin dependent diabetes mellitus; lowers hepatic fatty degeneration; improving liver function by reducing alanine transaminase and aspartate transaminase levels |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153743 Methods relating to the treatment of fibrosis |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080152725 Methods and kits for co-administration of nutritional supplements |
| 06/26/2008 | US20080152709 Clonidine composition and method of use |
| 06/26/2008 | US20080152696 Nutritional supplement for children from infants to adolescents; tablets, capsules or reconstitutable powders containing partially hydrolyzed recombinant leptin |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | DE102006062250A1 Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden Use of a composition of minerals and / or vitamins and optionally acetogenic and / or butyrogenic bacteria for oral or rectal administration for the treatment and prevention of abdominal discomfort |
| 06/26/2008 | CA2839162A1 Methods for the treatment of il-1-.beta. related diseases |
| 06/26/2008 | CA2673592A1 Methods for the treatment of il-1.beta. related diseases |
| 06/26/2008 | CA2673359A1 Cb1 receptor modulators |
| 06/26/2008 | CA2673358A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | CA2673177A1 Modulators of cb1 receptors |
| 06/26/2008 | CA2672761A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cpti) |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/26/2008 | CA2671535A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | CA2670839A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/25/2008 | EP1935890A1 2-heteroaryl-substituted indole derivative |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935883A1 Oxindole derivative as feeding control agent |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 06/25/2008 | EP1935432A1 Medical agent containing insulin resistance improving agent |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935424A1 Pharmaceutical compositions comprising combined antidiabetic substances for use in diabetes mellitus |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1934245A1 Y2 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1934217A1 New compounds ii |
| 06/25/2008 | EP1934198A2 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 06/25/2008 | EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 06/25/2008 | EP1934175A2 Anti-hypercholesterolemic compounds |
| 06/25/2008 | EP1933862A2 Methods and compositions for oral administration of proteins |
| 06/25/2008 | EP1933851A1 Vitamin b-12 compositions |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1933821A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 06/25/2008 | EP1933818A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 06/25/2008 | EP1807398B1 New indole or benzimidazole derivatives |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | CN101208307A Process for preparing amorphous rosuvastatin calcium free of impurities |
| 06/25/2008 | CN101208304A Quinoline 3-sulfonate esters as NK3 receptor modulators |
| 06/25/2008 | CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA |
| 06/25/2008 | CN101205236A Pyridinedicarboxylic acid vanadyl complexes as well as agent, tablet, capsule and uses thereof |
| 06/25/2008 | CN101204573A Medicine foe diabetes mellitus |
| 06/25/2008 | CN101204571A Edible Chinese traditional medicine composite for diabetes mellitus and preparation method thereof |
| 06/25/2008 | CN101204549A Composite of Chinese traditional medicine for diabetes mellitus |
| 06/25/2008 | CN101204504A Medicament composite for diabetes mellitus and preparation method threreof |
| 06/25/2008 | CN101204466A Novel antidiabetic |
| 06/25/2008 | CN101204465A Rehmanniae thirstiness-dispelling tea |
| 06/25/2008 | CN101204430A Extractive of total peony ladves glucoside, preparation method and uses thereof |
| 06/25/2008 | CN101204428A Substance extracted from giant knotweed for diabetes mellitus and complication thereof |
| 06/25/2008 | CN101204418A Application of Cajanus cajan L. extracts on preparating hyperlipemia medicine |
| 06/25/2008 | CN101204400A Prescripton and preparing method of colla corii asini line products |
| 06/25/2008 | CN101204394A Composite containing pioglitazone HCL and repaglinide |
| 06/25/2008 | CN101204391A Isoflavone compound curing atherosclerosis through strengthening reverse cholesterol transport mechanism and composite thereof |
| 06/25/2008 | CN101204239A Celery red juice and its processing method thereof |
| 06/25/2008 | CN101204230A Further processing for tenebrio molitor and uses thereof |
| 06/25/2008 | CN101204226A Series of functional food containing caricapapaya fruit active protease and manufacture method thereof |
| 06/25/2008 | CN101204210A Buckwheat-boiled noodle and manufacture method thereof |
| 06/25/2008 | CN101204199A Pet dog beverage additive and beverage thereof |
| 06/25/2008 | CN101204185A Balsam-coffee-juice and manufacture method thereof |
| 06/25/2008 | CN101204181A Cosmetic losing weight beverage and manufacture method |
| 06/25/2008 | CN101204176A Milk chaperone |
| 06/25/2008 | CN101204169A Strengthening nutritional additive powder with high dietary fiber |
| 06/25/2008 | CN101204166A Single nutritional strengthening component flour |
| 06/25/2008 | CN100396770C Microbial L. rhamnosus GM-020 and its use for treating obesity |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396320C Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst |
| 06/25/2008 | CN100396303C Deer fetus-pearl capsule |
| 06/25/2008 | CN100396296C Health product capsule to replenish the calcium, enliven the spleen, nourish the kidney and inhance body immunity |
| 06/25/2008 | CN100396287C Formulation containing phosphate derivatives of electron transfer agents |
| 06/25/2008 | CN100396283C Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/25/2008 | CN100396189C Fruit food for nourishing liver and reducing fat |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390809 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390509 Compositions and methods for nutrition supplementation |
| 06/24/2008 | US7390505 Nanoparticulate topiramate formulations |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/24/2008 | US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/19/2008 | WO2008073825A1 Lxr and fxr modulators |
| 06/19/2008 | WO2008073770A1 Use of pkc inhibitors in transplantation |